User profiles for P. Hagedoorn

Peter-Leon Hagedoorn

Associate Professor Biocatalysis, Delft University of Technology
Verified email at tudelft.nl
Cited by 3923

Dry powder inhalation: past, present and future

AH de Boer, P Hagedoorn, M Hoppentocht… - Expert opinion on …, 2017 - Taylor & Francis
… 55.de Boer AH, Gjaltema D, Hagedoorn P. Inhalation characteristics and their effects on
in vitro drug delivery from dry powder inhalers. Part 2: effect of peak flow rate (PIFR) and …

[HTML][HTML] Unity in the biochemistry of the iron-storage proteins ferritin and bacterioferritin

K Honarmand Ebrahimi, PL Hagedoorn… - Chemical …, 2015 - ACS Publications
Life on earth is dependent on the catalytic activity of a number of different metal ions in their
polypeptide scaffold. Of these metals iron is widely used for catalysis of many reactions by …

Air classifier technology (ACT) in dry powder inhalation: Part 1. Introduction of a novel force distribution concept (FDC) explaining the performance of a basic air …

AH De Boer, P Hagedoorn, D Gjaltema, J Goede… - International journal of …, 2003 - Elsevier
Air classifier technology (ACT) is introduced as part of formulation integrated dry powder
inhaler development (FIDPI) to optimise the de-agglomeration of inhalation powders. Carrier …

[HTML][HTML] Technological and practical challenges of dry powder inhalers and formulations

M Hoppentocht, P Hagedoorn, HW Frijlink… - Advanced drug delivery …, 2014 - Elsevier
In the 50 years following the introduction of the first dry powder inhaler to the market,
several developments have occurred. Multiple-unit dose and multi-dose devices have been …

Characterization of inhalation aerosols: a critical evaluation of cascade impactor analysis and laser diffraction technique

AH De Boer, D Gjaltema, P Hagedoorn… - International journal of …, 2002 - Elsevier
Cascade impactor analysis is the standard technique for in vitro characterization of aerosol
clouds generated by medical aerosol generators. One important reason for using this inertial …

[HTML][HTML] The clinical relevance of dry powder inhaler performance for drug delivery

P Demoly, P Hagedoorn, AH de Boer, HW Frijlink - Respiratory medicine, 2014 - Elsevier
… Oropharyngeal deposition increased for all particle sizes at the higher IFR, but this was
significantly greater for the larger particles (p < 0.001). These findings highlight the dynamic …

[HTML][HTML] Can 'extrafine'dry powder aerosols improve lung deposition?

AH De Boer, D Gjaltema, P Hagedoorn… - European Journal of …, 2015 - Elsevier
… Impactor cups were coated using a mixture of Brij 35-p in ethanol with glycerol as described
… Frijlink are speakers for various pharmaceutical companies and Paul Hagedoorn is a …

Developments and strategies for inhaled antibiotic drugs in tuberculosis therapy: a critical evaluation

M Hoppentocht, P Hagedoorn, HW Frijlink… - European Journal of …, 2014 - Elsevier
Inhaled antibiotics have been a valuable tool in treating pulmonary infections in cystic fibrosis
patients for decades, and the pulmonary route is now becoming increasingly interesting for …

[HTML][HTML] New mechanisms to explain the effects of added lactose fines on the dispersion performance of adhesive mixtures for inhalation

…, AJ Lexmond, M van den Noort, P Hagedoorn… - PloS one, 2014 - journals.plos.org
Fine excipient particles or ‘fines’ have been shown to improve the dispersion performance of
carrier-based formulations for dry powder inhalation. Mechanistic formulation studies have …

Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers Part 2: Effect of peak flow rate (PIFR) and inspiration time on the in vitro …

AH De Boer, D Gjaltema, P Hagedoorn - International journal of …, 1996 - Elsevier
Three commercial dry powder inhalers with completely different dosing and powder
disintegration principles were evaluated in an in vitro deposition study. A four-stage cascade …